Lilly Unveils Landmark Phase 3 Data for Foundayo and Retatrutide at ADA 2026
INDIANAPOLIS, May 28, 2026 Eli Lilly and Company has announced a major slate of scientific presentations for the American...
Eli Lilly
Advertisement
Merz and Kvvit Partner to Expand INBRIJA Access
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
Lilly Acquires Curevo, LimmaTech and Vaccine Company
INDIANAPOLIS, United States, May 26, 2026 Eli Lilly and Company has announced three major biotechnology acquisitions aimed at significantly...
Lilly’s VERVE-102 Shows Durable LDL-C Reduction
Indianapolis, Indiana, USA, May 25, 2026 Eli Lilly and Company has announced positive Phase 1b clinical results for VERVE-102,...
Lilly’s Foundayo Shows Strong Weight Loss in Seniors
Indianapolis, Indiana, USA – May 22, 2026 Eli Lilly and Company announced new clinical analysis from the Phase 3...
Advertisements
Lilly Acquires Engage Bio for Genetic Medicines
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
Eli Lilly Retatrutide Phase 3 Trial Delivers Major Weight Loss
INDIANAPOLIS, May 21, 2026 Eli Lilly and Company announced positive topline results from its pivotal Phase 3 TRIUMPH-1 clinical...
Lilly Partners With UNICEF to Expand Pediatric Healthcare Access
NEW YORK and INDIANAPOLIS, May 14, 2026 Eli Lilly and Company and UNICEF USA announced a major global healthcare...
Eli Lilly Strengthens GLP-1 Leadership With New Foundayo Trial Results
INDIANAPOLIS, May 12, 2026 Eli Lilly and Company has reported positive results from two major late-phase obesity trials showing...
Lilly Expands Indiana Manufacturing With $4.5B
LEBANON, Indiana, United States – May 6, 2026 Eli Lilly and Company has announced an additional $4.5 billion investment...
Advertisement
